Patent Assignment
Reel/Frame 071140/0893
Assignment of Assignor's Interest
Recorded: 2025-05-16
Pages: 2
Assignee
IDORSIA PHARMACEUTICALS LTD
HEGENHEIMERMATTWEG 91, ALLSCHWIL, 4123, SWITZERLAND
Covered Property
(1)
Crystalline Form of (3S,7S,10R,13R)-13-Benzyl-20-Fluoro-7-Isobutyl-N-(2-(3-Methoxy-1,2,4-Oxadiazol-5-Yl)Ethyl)-6,9-Dimethyl-1,5,8,11-Tetraoxo-10-(2,2,2-Trifluoroethyl)-1,2,3,4,5,6,7,8,9,10,11,12,13,14-Tetradecahydro-[1]Oxa[4,7,10,14]Tetraazacycloheptadecino[16,17-F]Quinoline-3-Carboxamide
Application:
19/111,955 →
Publication:
US 2026/0098045
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.